medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2018, Number 3

<< Back Next >>

Rev Mex Urol 2018; 78 (3)

Prevalence of female sexual dysfunction at a tertiary care hospital in Mexico City

López-Maguey RP, Cantellano-Orozco M, Staufert-Gutiérrez JR, Gómez- Sánchez J, Herrera-Muñoz JA, Preciado-Estrella DA

Language: Spanish
References: 18
Page: 169-175
PDF size: 299.83 Kb.


ABSTRACT

Objective: To estimate the prevalence of female sexual dysfunction at a tertiary care hospital in Mexico City.
Materials and Methods: A prospective and descriptive study in which the Index of Female Sexual Function (IFSF) questionnaire was applied to women between 20 and 60 years of age that were in medical consultation, were part of the medical team, or belonged to the work force at the Hospital Dr. Manuel Gea González, within the time frame of November 2016 and June 2017. Sexual dysfunction was calculated for each domain with a score under 3. Normal sexual function was classified by a score above 28 and sexual dysfunction by a score below 28. The SPSS version 1.0.0 was used for the statistical analysis and group and domain comparisons were performed with the ANOVA test and the Student’s t test.
Results: A total of 171 questionnaires were applied. Mean participant age was 34.6 years, number of sexual partners within the last 4 months was 1.1, and BMI was 27.7 kg. Only 45 (35%) women presented with female sexual dysfunction and its prevalence increased in relation to age: it was 17% in women under 30 years of age and 66% in women above 40 years of age. The main disorders associated with sexual dysfunction were: reduced sexual desire (28%), inability to achieve orgasm (17%) or arousal (17%), deficient lubrication (11%), and dyspareunia (11%).
Conclusions: The prevalence of female sexual dysfunction was similar to that reported in the international literature (35 vs 38%). Even though a high rate of obesity was reported, it did not correlate with female sexual dysfunction.


REFERENCES

  1. Jaafarpour M, Khajavikhan J, Suhrabi Z. Female sexual dysfunction: prevalence and risk factors. J Clin Diag Res 2013;7(12):2877-2880.

  2. Pérez-Martínez C, Vargas-Díaz HB, Castolo M. Prevalencia de disfunción sexual femenina en una población que asiste a una unidad de urología. Rev Mex Urol 2008;68(2):98-102.

  3. McCabe M, Sharlip I, Elham A, et al. Definitions of sexual dysfunctions in women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015. J Sex Med 2016;13:135-143.

  4. Levin R, Both S, Georgiadis, et al. The physiology of female sexual function and the pathophysiology of female sexual dysfunction. (Committee 13A). J Sex Med 2016;13:733-759.

  5. Parish S, Goldstein AT, Goldstein SW, et al. Toward a more evidence-based nosology and nomenclature for female sexual dysfunctions-Part II. J Sex Med 2016;13(12):1888- 1906.

  6. Famer M, Yoon H, Goldstein I. Future targets for female sexual dysfunction. j Sex Med 2016;13:1147-1165.

  7. Salonia A, Munarriz RM, Naspro R, Nappi RE, Briganti A, Chionna R, et al. Women’s sexual dysfunction: a pathophysiological review. BJU Int. 2004;93:1156-64.

  8. Blümel JE, Binfa LE, Cataldo PA, et al. Índice de función sexual femenina: un test para evaluar la sexualidad de la mujer. Rev Chil Osbstet Ginecol 2004;69(2):118-125.

  9. Mishra VV, Nanda S, Vyas B, Aggarwal R, Choudhary S, Saini SR. Prevalence of female sexual dysfunction among Indian fertile females. J Midlife Health 2016;7:154-8.

  10. Stephenson KR, Toorabally N, Lyons L. Further validation of the Female Sexual Function Index: specificity and associations with clinical interview data. J Sex Marital Ther 2016;42:448- 461.

  11. Lou WJ, Chen B, Zhu L, Han SM, Xu T, Lang JH, Zhang L. Prevalence and factors associated with female sexual dysfunction in Beijing, China. Chin Med J 2017;130:1389-94.

  12. McCool M, Zuelke A, Theurich M. Prevalence of female sexual dysfunction among premonopausal women: a systematic reviwe and meta-analysis of observational studies. Sex Med Rev 2016;4(3):197-212.

  13. Rabiepoor S, Khalkhali HR, Sadeghi E. What kind of sexual dysfunction is most common among overweight and obese women in reproductive age? Int J Impot Res 2017;29(2):61-64.

  14. Worsley R, Bell R, Gatoulla p, et al. Pevalence and predictors of low sexual desire, sexually related personal distress, and hypoactive sexual desire dysfunction in a community-based sample of midlife women. J Sex Med 2017;14:675-686.

  15. Latif E, Diamond M. Arriving at the diagnosis of female sexual dysfunction. Fertil Steril 2013;100:898-904.

  16. Gamal El Atrash, Mohamed H, Hassan A. The assessment of sexual dysfunction in Egyptian women with lower urinary tract symptoms. Arab J Urol 2014;12(3):234-8.

  17. Shifren JL, Monz BU, Russo PA, et al. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 2008;112:970-978.

  18. Oksuz E, Malhan S. Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol. 2006;175:654-58.




2020     |     www.medigraphic.com